one
import
anthrop
mission
prevent
global
spread
infecti
diseas
vaccin
avail
prevent
treatment
infecti
diseas
avail
vaccin
develop
countri
adequ
report
simpl
easytous
noninvas
hydrogel
patch
transcutan
vaccin
system
antigen
ag
specif
igg
product
induc
appli
agimmers
patch
nonpretr
mous
auricl
hairless
rat
back
skin
immunofluoresc
histochem
analysi
reveal
langerhan
cell
resid
epiderm
layer
captur
antigen
protein
deliv
hydrogel
patch
promot
penetr
antigen
protein
stratum
corneum
agcaptur
langerhan
cell
migrat
drain
lymph
node
humor
immun
elicit
transcutan
vaccin
system
demonstr
neutral
activ
adenovir
infect
passivechalleng
tetanu
toxin
experi
use
hydrogel
patch
transcutan
vaccin
system
facilit
global
distribut
effect
conveni
vaccin
infecti
diseas
common
caus
death
account
approxim
onethird
fatal
worldwid
recent
vigor
transnat
migrat
peopl
materi
reflect
develop
transport
facil
chang
social
structur
war
disast
increas
global
spread
emerg
infect
sever
acut
respiratori
syndrom
avian
influenza
viru
addit
declin
sanit
onset
drugresist
pathogen
organ
increas
spread
reemerg
infecti
diseas
tuberculosi
malaria
although
major
treatment
infecti
diseas
antibiot
administr
fundament
prophylaxi
vaccin
vaccin
develop
long
histori
recent
progress
due
new
approach
technolog
base
advanc
field
bacteriolog
virolog
molecular
biolog
convent
vaccin
perform
mainli
inject
sever
inher
problem
pain
requir
train
personnel
needlerel
diseas
injuri
storag
transport
issu
area
vaccin
coverag
infect
low
due
failur
followup
well
lack
train
medic
personnel
facil
thu
develop
easytous
needlefre
noninvas
vaccin
method
urgent
task
vaccin
rout
replac
inject
transcutan
immun
simpl
easi
noninvas
approach
skin
import
immun
function
proinflammatori
organ
epidermi
dermi
highli
popul
dendrit
cell
potent
antigenpres
cell
apc
import
immunostimulatori
migratori
activ
langerhan
cell
lc
constantli
expos
extern
antigen
ag
pathogen
cutan
counterpart
dendrit
cell
act
profession
apc
induc
agspecif
cell
adapt
immun
respons
also
initi
cascad
innat
immun
respons
sens
danger
signal
thu
ag
effici
deliv
lc
resid
epiderm
layer
transcutan
vaccin
might
elicit
effect
immun
respons
difficult
effici
deliv
adequ
ag
lc
stratum
corneum
physic
barrier
substanc
penetr
although
microneedl
iontophoresi
method
develop
overcom
issu
method
fraught
risk
inflamm
infect
due
breakdown
stratum
corneum
addit
microneedl
iontophoresi
method
problem
microneedl
remain
bodi
iontophoresi
method
requir
complic
equip
present
studi
develop
simpl
easytous
noninvas
transcutan
vaccin
system
use
novel
hydrogel
patch
innov
vaccin
system
might
promot
penetr
antigen
protein
stratum
corneum
induc
agspecif
humor
immun
respons
capabl
neutral
viral
infect
bacteri
toxin
femal
balbc
icr
mice
week
old
femal
hairless
rat
week
old
purchas
slc
inc
hamamatsu
japan
anim
handl
accord
osaka
univers
kyoto
pharmaceut
univers
guidelin
welfar
experiment
anim
research
protocol
describ
report
review
approv
anim
care
use
committe
osaka
univers
cell
helper
cell
line
adenovir
vector
ad
propag
purchas
american
type
cultur
collect
manassa
va
maintain
dulbecco
modifi
eagl
medium
contain
fetal
bovin
serum
transderm
adhes
matrix
compris
crosslink
cosm
pharmaceut
co
ltd
kyoto
japan
acryl
medic
adhes
octyldodecyl
lactat
glycerin
sodium
hyaluron
coat
solut
prepar
dissolv
compon
ethyl
acetateaceton
water
mixtur
matrix
prepar
cast
coat
solut
knife
onto
polyest
releas
liner
matrix
allow
stand
room
temperatur
min
subsequ
ovendri
min
remov
residu
organ
solvent
dri
film
lamin
onto
polyest
film
replicationdefici
ad
base
adenoviru
serotyp
backbon
delet
region
adluc
express
firefli
luciferas
control
cytomegaloviru
promot
previous
construct
improv
vitro
ligat
method
adluc
propag
cell
purifi
two
round
cesium
chlorid
gradient
ultracentrifug
dialyz
store
vector
particl
titer
evalu
spectrophotometr
use
method
maizel
et
al
ad
capsid
protein
solut
prepar
sonic
adluc
suspens
protein
concentr
determin
use
dc
protein
assay
kit
biorad
tokyo
japan
ovalbumin
ova
kda
sigmaaldrich
inc
st
loui
mo
adderiv
protein
major
capsid
protein
hexon
kda
tetanu
toxoid
kda
kindli
provid
research
foundat
microbi
diseas
osaka
univers
suita
japan
use
ag
vaccin
procedur
shown
supplementari
fig
briefli
ag
solut
contain
antigen
protein
phosphatebuff
salin
pb
drop
surfac
hydrogel
patch
formul
cm
cm
water
absorb
patch
appli
auricl
skin
mice
back
skin
hairless
rat
h
patch
cover
wound
manag
film
bioclus
johnson
johnson
medic
ltd
tokyo
japan
allow
better
skin
adher
case
auricl
skin
mice
tapestrip
stroke
use
adhes
tape
scotch
minneapoli
mn
place
patch
filter
paper
advantec
toyo
roshi
kaisha
ltd
tokyo
japan
use
vaccin
devic
instead
patch
procedur
repeat
two
three
time
everi
week
anim
belong
posit
control
group
intraderm
inject
ag
solut
use
schedul
two
week
final
vaccin
serum
collect
anim
agspecif
ab
titer
determin
use
enzymelink
immunosorb
assay
elisa
endpoint
titer
agspecif
ab
express
reciproc
log
last
dilut
show
absorb
unit
subtract
background
describ
previous
patch
contain
texasredlabel
ova
trova
invitrogen
carlasbad
ca
put
auricl
skin
mice
harvest
auricl
embed
oct
compound
sakura
finetechn
co
ltd
tokyo
japan
frozen
liquid
nitrogen
likewis
patch
applic
place
skin
h
frozen
frozen
section
thick
mount
perma
fluor
thermo
shandon
pittsburgh
pa
photograph
use
fluoresc
microscopi
keyenc
corpor
osaka
japan
patch
contain
trova
appli
auricl
skin
mice
two
hour
later
auricl
harvest
mice
epiderm
sheet
prepar
accord
method
mackenzi
squier
epiderm
sheet
fix
cold
aceton
min
wash
block
bovin
serum
albumin
bsa
pb
cervic
ln
harvest
mice
treatment
patch
contain
trova
ln
embed
oct
compound
frozen
liquid
nitrogen
frozen
section
thick
fix
paraformaldehyd
min
wash
block
bsapb
epiderm
sheet
ln
section
stain
antimous
ab
ebiosci
san
diego
ca
overnight
sampl
mount
perma
fluor
photograph
use
fluoresc
microscopi
two
week
final
vaccin
mice
vaccin
twice
ad
protein
intraven
inject
adluc
vector
particl
titer
two
day
later
liver
remov
weigh
homogen
pb
contain
aprotinin
phenylmethylsulfonyl
fluorid
luciferas
activ
homogen
determin
luciferas
assay
system
promega
madison
wi
two
week
final
vaccin
test
sera
collect
hairless
rat
vaccin
three
time
tetanu
toxoid
icr
mice
inject
subcutan
mixtur
test
sera
dilut
solut
contain
ng
tetanu
toxin
tetanospasmin
sigmaaldrich
inc
incub
h
mice
monitor
surviv
everi
h
h
transcutan
vaccin
ova
intact
auricl
skin
significantli
increas
antiova
igg
titer
sera
two
mous
strain
balbc
fig
effect
tend
superior
transcutan
vaccin
tapestrip
skin
mice
inject
intraderm
ova
solut
highest
titer
effect
transcutan
vaccin
use
patch
contain
ova
compar
inject
ova
fig
transcutan
vaccin
induc
mainli
antiova
igg
subclass
fig
hand
ova
inject
mice
induc
specif
ova
cytokin
cytokin
induc
class
switch
respect
result
subclass
analysi
indic
transcutan
vaccin
use
hydrogel
patch
predominantli
induc
humor
immun
respons
rather
cellular
immun
respons
addit
antiova
iga
titer
detect
fecal
extract
nasal
cavitywash
fluid
ovaspecif
cytotox
lymphocyt
respons
detect
splenocyt
mice
vaccin
transcutan
mice
immun
intraderm
supplementari
fig
thu
transcutan
vaccin
use
agimmers
patch
formul
elicit
humor
immun
respons
agspecif
dominantli
produc
gener
spread
ag
solut
onto
intact
skin
induc
immun
respons
stratum
corneum
form
barrier
foreign
substanc
invas
therefor
hypothes
use
patch
formul
could
acceler
transderm
penetr
antigen
protein
maintain
high
ag
concentr
skin
surfac
hydrogel
patch
formul
immers
trova
solut
form
concentr
ag
layer
surfac
fig
maintain
least
h
room
temperatur
addit
ag
layer
remain
surfac
patch
formul
applic
auricl
skin
mice
fig
suggest
patch
formul
contain
ag
gener
maintain
larg
gradient
ag
concentr
produc
drive
forc
necessari
transderm
penetr
antigen
protein
next
analyz
local
ag
tapestrip
intact
skin
treat
patch
formul
contain
trova
two
hour
patch
applic
although
ag
distribut
patch
stratum
corneum
obviou
ag
penetr
epiderm
layer
intact
skin
tapestrip
skin
fig
e
mark
penetr
ag
epiderm
layer
tapestrip
skin
applic
fig
wherea
ag
deliveri
epiderm
layer
intact
skin
requir
patch
applic
fig
find
indic
approach
use
hydrogel
patch
promot
penetr
antigen
protein
stratum
corneum
effici
ag
deliveri
lc
resid
epiderm
layer
critic
induct
potent
immun
respons
transcutan
vaccin
therefor
perform
immunohistochem
analysi
lc
epiderm
sheet
drain
ln
section
prepar
mice
treat
trovacontain
patch
tapestrip
skin
lc
epiderm
layer
captur
trova
deliv
patch
applic
fig
trace
biodistribut
lc
captur
ag
analyz
local
trova
lc
drain
cervic
ln
isol
mice
transcutan
treatment
trovaimmers
patch
fig
yellow
fluoresc
spot
indic
trova
local
accord
lc
local
observ
merg
imag
ln
section
prepar
mice
intact
skin
higher
frequenc
yellow
spot
observ
mice
tapestrip
skin
addit
ag
deliv
epiderm
layer
seem
enter
directli
lymph
vessel
red
fluoresc
alon
detect
drain
ln
find
indic
ag
transport
ln
also
agcaptur
lc
migrat
epiderm
layer
region
ln
would
greatli
contribut
trigger
amplifi
agspecif
immun
respons
induc
transcutan
vaccin
use
hydrogel
patch
formul
serum
antiad
igg
titer
increas
mice
vaccin
transcutan
adderiv
protein
appli
intact
skin
titer
order
tend
induc
ovaimmun
model
via
vaccin
rout
intraderm
inject
n
transcutan
immun
intact
skin
transcutan
immun
tapestrip
skin
fig
evalu
neutral
activ
adspecif
ab
intraven
inject
adluc
mice
week
final
vaccin
two
day
later
luciferas
activ
liver
mice
vaccin
transcutan
intact
skin
repress
level
compar
intraderm
inject
fig
thu
transcutan
vaccin
use
patch
formul
potenti
protect
neutral
viral
infect
result
tetanu
toxoid
vaccin
summar
tabl
three
vaccin
toxoidcontain
patch
induc
increas
antitoxoid
igg
titer
level
greater
hairless
rat
wherea
ab
induc
rat
filter
paper
appli
instead
patch
ab
titer
slightli
higher
group
vaccin
intraderm
inject
group
vaccin
transcutan
toxoidcontain
patch
hairless
rat
mous
model
supplementari
fig
data
demonstr
transcutan
vaccin
system
induc
agspecif
ab
product
back
skin
hairless
rat
thicker
stratum
corneum
mous
auricl
skin
passivechalleng
experi
use
mice
inject
subcutan
mixtur
test
sera
tetanu
toxin
mice
treat
either
toxoidfre
patch
toxoidcontain
filter
paper
die
hand
sera
hairless
rat
inject
three
time
toxoid
show
complet
protect
lethal
toxin
challeng
dilut
sera
collect
hairless
rat
vaccin
toxoidcontain
patch
neutral
tetanu
toxin
mice
dilut
addit
test
sera
transcutan
vaccin
group
allow
toxinchalleng
mice
surviv
dilut
taken
togeth
result
indic
transcutan
vaccin
use
hydrogel
patch
promis
approach
develop
simpl
easytous
fig
section
trovaimmers
hydrogel
patch
formul
local
trova
epiderm
skin
sheet
skin
section
mice
vaccin
transcutan
patch
contain
trova
put
intact
tapestrip
auricl
skin
mice
variou
period
patch
auricl
harvest
frozen
frozen
section
thick
photograph
use
fluoresc
microscopi
patch
applic
b
patch
h
skin
applic
c
intact
skin
h
patch
applic
intact
skin
h
patch
applic
e
tapestrip
skin
h
patch
applic
f
tapestrip
skin
h
patch
applic
fig
fluoresc
microscop
imag
epiderm
sheet
applic
patch
contain
trova
patch
contain
trova
appli
intact
tapestrip
auricl
skin
mice
two
hour
later
auricl
harvest
epiderm
sheet
prepar
epiderm
sheet
stain
antimous
ab
lc
photograph
use
fluoresc
microscopi
noninvas
tetanu
vaccin
although
optim
vaccin
protocol
would
requir
induc
protect
activ
compar
inject
vaccin
find
present
studi
demonstr
origin
hydrogel
patch
formul
induc
agspecif
humor
immun
respons
base
promot
ag
deliveri
lc
stratum
corneum
although
theori
transderm
drug
deliveri
suggest
skin
structur
composit
allow
penetr
materi
larger
da
transcutan
vaccin
system
deliv
antigen
protein
kda
epiderm
layer
propos
follow
mechan
ag
penetr
stratum
corneum
first
concentr
antigen
protein
surfac
patch
might
gener
high
concentr
gradient
antigen
protein
skin
critic
produc
drive
forc
necessari
acceler
passiv
diffus
distribut
theori
support
observ
distribut
trova
epiderm
layer
simpli
result
spread
trova
solut
intact
skin
surfac
data
shown
applic
filter
paper
immers
ag
solut
enhanc
either
ag
penetr
ab
titer
second
humect
hydrat
skin
hydrogel
patch
appli
might
fig
fluoresc
microscopi
imag
drain
cervic
ln
section
applic
patch
contain
trova
patch
contain
trova
appli
intact
tapestrip
auricl
skin
mice
cervic
ln
harvest
mice
patch
treatment
frozen
section
thick
stain
antimous
ab
photograph
use
fluoresc
microscopi
loosen
intercellular
gap
stratum
corneum
contribut
improv
penetr
watersolubl
substanc
observ
ag
penetr
via
patch
system
occur
mainli
intercellular
gap
stratum
corneum
fact
sever
report
increas
water
content
stratum
corneum
lead
increas
membran
fluiditi
decreas
electr
resist
third
possibl
antigen
protein
penetr
epiderm
layer
hair
follicl
report
hair
follicl
allow
even
nanoparticl
reach
epiderm
layer
skin
orchestr
mechan
patch
vaccin
system
promot
penetr
watersolubl
macromolecular
protein
stratum
corneum
furthermor
find
immun
induct
transcutan
vaccin
intact
skin
compar
superior
vaccin
tapestrip
skin
permit
prompt
abund
ag
penetr
suggest
stratum
corneum
oper
sustainedreleas
system
antigen
protein
notabl
characterist
immun
respons
induc
agimmers
patch
vaccin
predomin
activ
humor
immun
igg
product
mice
vaccin
transcutan
ova
exhibit
increas
antiova
subclass
titer
subclass
titer
wherea
intraderm
inject
ova
induc
product
subclass
specif
ova
distinct
immun
respons
intraderm
inject
transcutan
vaccin
seem
due
differ
agcaptur
apc
subset
site
ag
deposit
ag
administ
transcutan
would
captur
mainli
lc
resid
epiderm
layer
lc
produc
chemokin
rather
littl
induct
immun
respons
hand
ag
inject
intraderm
might
captur
lc
dermal
dendrit
cell
activ
immun
respons
believ
phenotyp
characterist
agcaptur
apc
administr
site
region
ln
determin
balanc
immun
respons
induc
type
vaccin
although
detail
analys
necessari
elucid
mechan
patch
vaccin
properti
may
advantag
treat
autoimmun
diseas
correct
balanc
addit
transcutan
vaccin
system
might
contribut
develop
immunotherapi
alzheim
diseas
schenk
et
al
demonstr
intraperiton
vaccin
pdapp
transgen
mous
model
alzheim
diseas
peptid
plu
freund
adjuv
result
dramat
reduct
cerebr
amyloidosi
therapeut
approach
clearli
highli
efficaci
howev
safeti
strategi
import
concern
clinic
trial
approxim
patient
administ
synthet
peptid
plu
adjuv
develop
asept
meningoenceph
like
mediat
braininfiltr
activ
cell
advers
effect
seem
associ
activ
immun
vaccin
peptid
recent
nikol
et
al
demonstr
transcutan
immun
capabl
induc
immun
predominantli
constitut
effect
potenti
safe
treatment
strategi
alzheim
diseas
therefor
transcutan
vaccin
system
use
hydrogel
patch
formul
promis
establish
easytous
efficaci
safe
immunotherapi
alzheim
diseas
conclus
transcutan
vaccin
system
use
hydrogel
patch
formul
deliv
antigen
protein
lc
resid
epiderm
layer
without
destroy
remov
stratum
corneum
induc
immun
respons
product
neutral
ab
effect
prevent
viral
bacteri
infect
simpl
easytous
noninvas
vaccin
could
contribut
greatli
prevent
global
diffus
emerg
mice
transcutan
intraderm
vaccin
twice
interv
ad
protein
two
week
final
vaccin
sera
collect
mice
assay
determin
adspecif
igg
titer
elisa
addit
mice
intraven
inject
adluc
vector
particl
titer
two
day
later
luciferas
activ
liver
homogen
determin
luciferas
assay
system
b
data
express
sd
result
five
mice
nd
detect
ts
tapestrip
tc
transcutan
vaccin
id
intraderm
vaccin
statist
signific
evalu
oneway
analysi
varianc
follow
tukey
test
multipl
comparison
p
b
p
b
versu
nonimmun
group
reemerg
infect
diseas
moreov
hydrogel
patch
formul
potenti
wide
varieti
applic
vaccineimmunotherapi
research
also
drug
deliveri
research
